Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan

Karmanos Cancer Institute at McLaren Greater Lansing is a clinical research site located in Lansing, Michigan, United States 48910.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute at McLaren Greater Lansing has participated in 62 clinical trials with 50 currently active.

Therapeutic areas: Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8.

Sponsors: National Cancer Institute (NCI), NRG Oncology, Barbara Ann Karmanos Cancer Institute.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute at McLaren Greater Lansing?

Karmanos Cancer Institute at McLaren Greater Lansing has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute at McLaren Greater Lansing conducted?

Karmanos Cancer Institute at McLaren Greater Lansing has 62 clinical trials on record, with 50 currently active. Their work covers Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8.

Is Karmanos Cancer Institute at McLaren Greater Lansing accredited by Crixeo Health?

Yes — Karmanos Cancer Institute at McLaren Greater Lansing holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Karmanos Cancer Institute at McLaren Greater Lansing?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.